GE Healthcare

 
GE Healthcare Life Sciences Part of GE Healthcare
  
items: total: checkout
 Location: Home > LitDocs > Instruction/protocol > EGFP-SMAD2 Adenoviral Vector Gene Delivery System GDS20003
Search
Advanced search
Search tips
Search: Literature
              MSDS
              Certificate of analysis
              Batch analysis sheets

On-line Ordering
Catalog Home
New products
Quick Order Form
Shopping Cart
Returns
Online ordering overview
Frequently Asked Questions

EGFP-SMAD2 Adenoviral Vector Gene Delivery System GDS20003

 (GDS20003PL Rev C print.pdf - 92 Kb)


Product Specification sheet for EGFP-SMAD2 :

The intracellular translocation of the EGFP-SMAD2 fusion protein can be monitored using fluorescence microscopes in the presence of an appropriate agonist such as transforming growth factor-b1 (TGF-b1), thereby providing a means of measuring SMAD2 activity and interrogating the TGF-b1 signalling pathway. The degree of activation of the TGF-b1 signaling pathway and SMAD2 can be quantified by measuring the cytoplasmic to nuclear ratio of fluorescence of the EGFP-SMAD2 fusion protein in different cellular contexts.






Feedback Form